Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders

New England Journal of Medicine

Volumn 330, Issue 9, 1994, Pages 597-601

  Shannon, Kevin M ^a   O'connell, Peter ^b   Martin, George A ^c   Paderanga, Dorothy ^a   Olson, Kristin ^a   Dinndorf, Patricia ^d   Mccormick, Frank ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c ONYX PHARMACEUTICALS   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GUANOSINE TRIPHOSPHATE; RAS PROTEIN; REGULATOR PROTEIN;

ALLELE; ARTICLE; BONE MARROW; CHILD; CLINICAL ARTICLE; DNA POLYMORPHISM; FEMALE; GENE LOSS; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LEUKEMOGENESIS; LEUKOCYTE; MALE; MYELOPROLIFERATIVE DISORDER; NEUROFIBROMATOSIS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; BASE SEQUENCE; BONE MARROW; CHILD; CHILD, PRESCHOOL; DNA PRIMERS; DNA, NEOPLASM; FEMALE; GENE DELETION; GENES, NEUROFIBROMATOSIS 1; HETEROZYGOTE; HUMANS; INFANT; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MOLECULAR SEQUENCE DATA; NEUROFIBROMATOSIS 1;

EID: 0027979146     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199403033300903     Document Type: Article

References (42)

1. Bourne HR, Sanders DA, McCormick F The GTPase superfamily: a conserved switch for diverse cell functions. Nature 1990; 348: 125-132
2. Hall A The cellular functions of small GTP-binding proteins. Science 1990; 249: 635-640
3. Rodenhuis S ras And human tumors. Semin Cancer Biol 1992; 3: 241-247
4. Ballester R, Marchuk D, Boguski M, The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990; 63: 851-859
5. Buchberg AM, Cleveland LS, Jenkins NA, Copeland NG Sequence homology shared by neurofibromatosis type-1 gene and IRA-1 and IRA-2 negative regulators of the RAS cyclic AMP pathway. Nature 1990; 347: 291-294
6. The neurofibromatosis type 1 gene encodes a protein related to GAP, G.F., Xu, P., O'Connell, D., Viskochil, Cell, (1990), 62, 599-608
7. Martin GA, Viskochil D, Bollag G, The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990; 63: 843-849
8. Xu GF, Lin B, Tanaka K, The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell 1990; 63: 835-841
9. Riccardi VM, Eichner JE. Neurofibromatosis: phenotype, natural history, and pathogenesis. Baltimore: Johns Hopkins University Press, 1986.
10. Weinberg RA Tumor suppressor genes. Science 1991; 254: 1138-1146
11. Skuse GR, Kosciolek BA, Rowley PT Molecular genetic analysis of tumors in von Recklinghausen neurofibromatosis: loss of heterozygosity for chromosome 17. Genes Chromosomes Cancer 1989; 1: 36-41
12. Menon AG, Anderson KM, Riccardi VM, Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A 1990; 87: 5435-5439
13. Glover TW, Stein CK, Legius E, Andersen LB, Brereton A, Johnson S Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes Chromosomes Cancer 1991; 3: 62-70
14. Xu W, Mulligan LM, Ponder MA, Loss of NF1 alleles in phaeochromocytomas from patients with type 1 neurofibromatosis. Genes Chromosomes Cancer 1992; 4: 337-342
15. Basu TN, Gutmann DH, Fletcher JA, Glover TW, Collins FS, Downward J Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 1992; 356: 713-715
16. DeClue JE, Papageorge AG, Fletcher JA, Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 1992; 69: 265-273
17. Legius E, Marchuk DA, Collins FS, Glover TW Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 1993; 3: 122-126
18. Gadner H, Haas OA Experience in pediatric myelodysplastic syndromes. Hematol Oncol Clin North Am 1992; 6: 655-672
19. Bader JL, Miller RW Neurofibromatosis and childhood leukemia. J Pediatr 1978; 92: 925-929
20. Castro-Malaspina H, Schaison G, Passe S, Subacute and chronic myelomonocytic leukemia in children (juvenile CML): clinical and hematologic observations, and identification of prognostic factors. Cancer 1984; 54: 675-686
21. Shannon KM, Watterson J, Johnson P, Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis. Blood 1992; 79: 1311-1318
22. Vogelstein B, Civin CI, Preisinger AC, RAS gene mutations in childhood acute myeloid leukemia: a Pediatric Oncology Group study. Genes Chromosomes Cancer 1990; 2: 159-162
23. Shannon KM, Turhan AG, Chang SSY, Familial bone marrow monosomy 7: evidence that the predisposing locus is not on the long arm of chromosome 7. J Clin Invest 1989; 84: 984-989
24. Andersen LB, Wallace MR, Marchuk DA, A highly polymorphic cDNA probe in the NF1 gene. Nucleic Acids Res 1991; 19: 3754-3754 abstract.
25. Andersen LB, Wallace MR, Marchuk DA, A polymorphic cDNA probe on chromosome 17q11.2 located within the NF1 gene [D17S376]. Nucleic Acids Res 1991; 19: 197-197 abstract.
26. Xu GF, Nelson L, O'Connell P, White R An Alu polymorphism intragenic to the neurofibromatosis type 1 gene (NF1). Nucleic Acids Res 1991; 19: 3764-3764
27. Andersen LB, Tarle SA, Marchuk DA, Legius E, Collins FS A compound nucleotide repeat in the neurofibromatosis (NF1) gene. Hum Mol Genet 1993; 2: 1083-1083 abstract.
28. Nakamura Y, Ballard L, Leppert M, Isolation and mapping of a polymorphic DNA sequence (pYNZ22) on chromosome 17p [D17S30]. Nucleic Acids Res 1988; 16: 5707-5707 abstract.
29. Futreal PA, Barrett JC, Wiseman RW An Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Res 1991; 19: 6977-6977 abstract.
30. Hollstein M, Sidransky D, Vogelstein B, Harris CC p53 Mutations in human cancers. Science 1991; 253: 49-53
31. Lubbert M, Mirro J Jr, Kitchingman G, Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. Oncogene 1992; 7: 263-268
32. Neubauer A, Shannon K, Liu E Mutations of the ras proto-oncogenes in childhood monosomy 7. Blood 1991; 77: 594-598
33. Weiss K, Stass S, Williams D, Childhood monosomy 7 syndrome: clinical and in vitro studies. Leukemia 1987; 1: 97-104
34. Freedman MH, Cohen A, Grunberger T, Central role of tumor necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia. Br J Haematol 1992; 80: 40-48
35. Emanuel PD, Bates LJ, Castleberry RP, Gualtieri RJ, Zuckerman KS Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood 1991; 77: 925-929
36. Satoh T, Nakafuku M, Miyajima A, Kaziro Y Involvement of ras p21 protein in signal-transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4. Proc Natl Acad Sci U S A 1991; 88: 3314-3318
37. The I, Murthy AE, Hannigan GE, Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat Genet 1993; 3: 62-66
38. Andersen LB, Fountain JW, Gutmann DH, Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nat Genet 1993; 3: 118-121
39. Noda M, Ko M, Ogura A, Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line. Nature 1985; 318: 73-75
40. Bar-Sagi D, Feramisco JR Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell 1985; 42: 841-848
41. Qui MS, Green SH PC12 cell neuronal differentiation is associated with prolonged p21ras activity and consequent prolonged ERK activity. Neuron 1992; 9: 705-717
42. Fong C-t, Brodeur GM Down's syndrome and leukemia: epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genet Cytogenet 1987; 28: 55-76